News
FDA Asks Novavax for Commitment on Post-Approval Studies for COVID Vaccine
Novavax on Wednesday said the U.S. Food and Drug Administration has asked the company to commit to produce more data on its COVID-19 vaccine if it is approved, after the agency missed a deadline to grant the shot a traditional approval.
The Slovak government has paused COVID-19 vaccine purchases based on safety concerns voiced by Prime Minister Robert Fico and ...
The World Vaccine Congress kicks off its annual conference this week in Washington, bringing together researchers, pharma ...
The FDA would also hold listening meetings to hear from people about their concerns about the components ... used in some flu shots—along with vaccine safety and efficacy. The FDA already ...
Al Jazeera on MSN9d
Fact check: Does a new study say the flu vaccine is dangerous?The study’s results indicated the cumulative incidence of influenza – or the number of new cases divided by the total number ...
New York Magazine on MSN3d
What It’s Like to Be a Vaccine Researcher in RFK Jr.’s AmericaHe is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...
13d
Officials at the Department of Health and Human Services have struggled to find records belonging to Dr. Tom Shimabukuro, the director of the CDC’s Immunization Safety Office.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback